Total Cholesterol and Lipoprotein Fractionation

Total cholesterol is the sum of the cholesterol carried in all lipoprotein classes, and lipoprotein fractionation is the process of partitioning that total into clinically meaningful components—chiefly the cholesterol carried by low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Because LDL delivers cholesterol to peripheral tissues and HDL participates in its return to the liver, separating the two fractions conveys far more about cardiovascular biology than the total alone.

Definition

Total cholesterol is the combined cholesterol content of all plasma lipoproteins; lipoprotein fractionation resolves this into the cholesterol carried by individual classes, most importantly LDL cholesterol (often estimated by the Friedewald equation or measured directly) and HDL cholesterol, with non-HDL cholesterol obtained by subtracting HDL cholesterol from the total.

Scope

This topic covers what total, LDL, and HDL cholesterol measure, how LDL cholesterol is derived by calculation or measured directly, the meaning of non-HDL cholesterol, and the analytical and pre-analytical issues that affect fractionation. It is a measurement and interpretation topic, not a source of diagnostic cut-points or treatment guidance.

Core questions

• What is the difference between total cholesterol and the cholesterol carried by individual lipoprotein classes?
• How is LDL cholesterol estimated, and when does the Friedewald equation fail?
• What does non-HDL cholesterol capture that LDL cholesterol does not?
• How do HDL and LDL differ in their physiological role in cholesterol transport?

Key concepts

• Total cholesterol as a summed quantity
• LDL cholesterol
• HDL cholesterol
• Friedewald equation
• Direct (homogeneous) LDL assays
• Non-HDL cholesterol
• LDL receptor pathway

Mechanisms

Cholesterol circulates esterified and unesterified within lipoprotein particles. LDL is the principal cholesterol-carrying particle delivering cholesterol to tissues via the LDL receptor pathway characterised by Brown and Goldstein, while HDL acquires cholesterol from tissues for reverse transport. In the laboratory, total and HDL cholesterol are measured enzymatically, and LDL cholesterol is classically calculated by the Friedewald equation as total cholesterol minus HDL cholesterol minus an estimate of VLDL cholesterol derived from triglycerides. This estimate degrades when triglycerides are high or LDL cholesterol is very low, motivating direct homogeneous LDL assays and the use of non-HDL cholesterol, which simply subtracts HDL cholesterol from total cholesterol to capture all apolipoprotein B-containing particles.

Clinical relevance

Total, LDL, HDL, and non-HDL cholesterol are core components of cardiovascular risk assessment and of monitoring responses to lipid-lowering measures. This entry explains what these fractions represent and how they are derived; it is reference material and does not specify target values or therapy for individuals.

Evidence & guidelines

Major dyslipidaemia guidelines incorporate LDL and non-HDL cholesterol into cardiovascular risk frameworks, and consensus laboratory statements address the limitations of estimated LDL cholesterol at very low concentrations and at high triglycerides. These are population-level and laboratory-practice documents rather than individualised recommendations.

History

The enzymatic measurement of cholesterol and the 1972 Friedewald equation made routine LDL cholesterol estimation feasible without ultracentrifugation, establishing the fractionated lipid panel as a standard test. Brown and Goldstein's elucidation of the LDL receptor pathway supplied the biological rationale for focusing on LDL cholesterol. As potent LDL-lowering therapies pushed concentrations lower, attention shifted toward direct assays and non-HDL cholesterol where the estimating equation becomes unreliable.

Debates

Calculated versus directly measured LDL cholesterol

The Friedewald estimate is convenient but inaccurate at high triglycerides and very low LDL cholesterol; whether to prefer direct homogeneous assays, alternative equations, or non-HDL cholesterol in these settings is an active laboratory and clinical-chemistry discussion.

Key figures

• William Friedewald
• Donald Fredrickson
• Michael Brown
• Joseph Goldstein

Seminal works

• friedewald-1972
• goldstein-brown-2009

Frequently asked questions

Is LDL cholesterol measured or calculated?

Traditionally it is calculated from total cholesterol, HDL cholesterol, and triglycerides using the Friedewald equation, though direct homogeneous assays exist and are preferred when the equation is unreliable, such as at high triglycerides or very low LDL cholesterol.

What is non-HDL cholesterol?

Non-HDL cholesterol is total cholesterol minus HDL cholesterol. It captures the cholesterol in all atherogenic apolipoprotein B-containing particles and does not depend on triglyceride-based estimation.